Latica offers a non‑invasive acoustic pulse device that delivers focused energy to the uterine lining to stimulate angiogenesis, reduce inflammation, and increase collagen production, thereby improving endometrial thickness and receptivity. The <10‑minute treatment can be integrated into existing IVF cycles without anesthesia, helping fertility clinics enhance implantation success rates.
Funding
Funding not disclosed
Founders
Product
Problem
A significant proportion of infertility cases stem from female reproductive issues such as poor endometrial thickness, chronic inflammation, infections, implantation failure, and endometriosis. Traditional interventions often involve invasive procedures or prolonged medication regimens, which can delay IVF cycles and increase patient discomfort.
Solution
Latica applies Acoustic Pulse Technology (APT) to address the underlying physiological factors that impede successful IVF outcomes. The device delivers focused acoustic pulses that stimulate angiogenesis, reduce inflammation, and promote collagen I and III synthesis within the uterine lining. By enhancing blood flow and tissue remodeling, APT improves endometrial receptivity and mitigates infection‑related damage without heating or radiation. The treatment lasts under ten minutes, requires no anesthesia, and can be scheduled alongside standard IVF protocols, allowing clinics to prepare patients more efficiently for embryo transfer.
Target Audience
The primary customers are IVF clinics, reproductive endocrinology practices, and fertility specialists seeking a rapid, non‑invasive adjunct to improve uterine conditions before embryo transfer.
Features
- Non‑invasive acoustic pulse emitter calibrated for uterine tissue, delivering therapeutic energy without thermal effects
- Protocol‑agnostic workflow that fits into existing IVF cycle timelines (procedure < 10 min)
- Clinically validated mechanisms: increased angiogenesis, anti‑inflammatory response, and upregulated collagen I/III production
- Targeted remediation of common female infertility factors: thin endometrium, chronic infections, implantation failure, and endometriosis
- Real‑time monitoring of pulse delivery parameters to ensure consistent dosing and safety
- HIPAA‑compliant data capture for treatment documentation and integration with clinic EMR systems
- Portable, single‑patient use system designed for outpatient fertility centers